News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
851,911 Results
Type
Article (86789)
Company Profile (704)
Press Release (764417)
Multimedia
Podcasts (141)
Webinars (19)
Section
Business (232789)
Career Advice (4132)
Deals (39754)
Drug Delivery (129)
Drug Development (91078)
Employer Resources (198)
FDA (18168)
Job Trends (17359)
News (396759)
Policy (39807)
Tag
Academia (3002)
Academic (2)
Accelerated approval (9)
Adcomms (32)
Allergies (106)
Alliances (56970)
ALS (115)
Alzheimer's disease (1548)
Antibody-drug conjugate (ADC) (186)
Approvals (18117)
Artificial intelligence (384)
Autoimmune disease (35)
Automation (18)
Bankruptcy (406)
Best Places to Work (12633)
BIOSECURE Act (22)
Biosimilars (127)
Biotechnology (481)
Bladder cancer (96)
Brain cancer (39)
Breast cancer (381)
Cancer (2992)
Cardiovascular disease (240)
Career advice (3540)
Career pathing (34)
CAR-T (202)
CDC (39)
Cell therapy (558)
Cervical cancer (24)
Clinical research (74160)
Collaboration (1077)
Company closure (3)
Compensation (663)
Complete response letters (30)
COVID-19 (2897)
CRISPR (65)
C-suite (326)
Cystic fibrosis (117)
Data (2946)
Decentralized trials (2)
Denatured (49)
Depression (68)
Diabetes (374)
Diagnostics (6970)
Digital health (26)
Diversity (9)
Diversity, equity & inclusion (49)
Drug discovery (172)
Drug pricing (150)
Drug shortages (35)
Duchenne muscular dystrophy (129)
Earnings (97440)
Editorial (48)
Employer branding (25)
Employer resources (169)
Events (131369)
Executive appointments (902)
FDA (19825)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (10)
Funding (986)
Gene editing (144)
Generative AI (37)
Gene therapy (425)
GLP-1 (924)
Government (5246)
Grass and pollen (6)
Guidances (180)
Healthcare (20915)
Huntington's disease (31)
IgA nephropathy (42)
Immunology and inflammation (175)
Immuno-oncology (9)
Indications (40)
Infectious disease (3080)
Inflammatory bowel disease (163)
Inflation Reduction Act (13)
Influenza (66)
Intellectual property (119)
Interviews (813)
IPO (17900)
IRA (55)
Job creations (5192)
Job search strategy (2863)
Kidney cancer (15)
Labor market (55)
Layoffs (584)
Leadership (26)
Legal (10131)
Liver cancer (84)
Lung cancer (423)
Lymphoma (207)
Machine learning (9)
Management (65)
Manufacturing (420)
MASH (94)
Medical device (14706)
Medtech (14711)
Mergers & acquisitions (22548)
Metabolic disorders (943)
Multiple sclerosis (103)
NASH (23)
Neurodegenerative disease (137)
Neuropsychiatric disorders (40)
Neuroscience (2273)
NextGen: Class of 2025 (7687)
Non-profit (5089)
Now hiring (48)
Obesity (485)
Opinion (288)
Ovarian cancer (100)
Pain (116)
Pancreatic cancer (121)
Parkinson's disease (197)
Partnered (25)
Patents (306)
Patient recruitment (155)
Peanut (55)
People (65652)
Pharmaceutical (143)
Pharmacy benefit managers (24)
Phase I (22895)
Phase II (32199)
Phase III (24244)
Pipeline (1629)
Policy (233)
Postmarket research (3552)
Preclinical (10337)
Press Release (72)
Prostate cancer (145)
Psychedelics (41)
Radiopharmaceuticals (277)
Rare diseases (505)
Real estate (7400)
Recruiting (76)
Regulatory (27068)
Reports (61)
Research institute (2664)
Resumes & cover letters (650)
Rett syndrome (9)
RNA editing (9)
RSV (55)
Schizophrenia (92)
Series A (165)
Series B (109)
Service/supplier (30)
Sickle cell disease (65)
Special edition (22)
Spinal muscular atrophy (167)
Sponsored (36)
Startups (4300)
State (2)
Stomach cancer (16)
Supply chain (81)
Tariffs (64)
The Weekly (90)
Vaccines (894)
Venture capital (54)
Weight loss (328)
Women's health (48)
Worklife (20)
Date
Today (96)
Last 7 days (633)
Last 30 days (2725)
Last 365 days (34109)
2025 (17450)
2024 (38139)
2023 (42568)
2022 (53928)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37191)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1272)
Alabama (70)
Alaska (7)
Arizona (280)
Arkansas (14)
Asia (50480)
Australia (8873)
California (7613)
Canada (2342)
China (710)
Colorado (331)
Connecticut (342)
Delaware (200)
Europe (115803)
Florida (1126)
Georgia (260)
Hawaii (2)
Idaho (66)
Illinois (728)
India (32)
Indiana (382)
Iowa (18)
Japan (226)
Kansas (115)
Kentucky (32)
Louisiana (18)
Maine (73)
Maryland (1087)
Massachusetts (5825)
Michigan (273)
Minnesota (477)
Mississippi (3)
Missouri (98)
Montana (32)
Nebraska (26)
Nevada (81)
New Hampshire (73)
New Jersey (2133)
New Mexico (31)
New York (2145)
North Carolina (1225)
North Dakota (10)
Northern California (3274)
Ohio (245)
Oklahoma (17)
Oregon (48)
Pennsylvania (1631)
Puerto Rico (18)
Rhode Island (39)
South America (1654)
South Carolina (35)
South Dakota (1)
Southern California (2795)
Tennessee (127)
Texas (1158)
United States (28808)
Utah (226)
Virginia (208)
Washington D.C. (80)
Washington State (675)
West Virginia (4)
Wisconsin (83)
There are 851,911 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
MASH
Altimmune Nosedives on Mixed Mid-Stage MASH Data for GLP-1/Glucagon Drug
Altimmune’s pemvidutide failed to significantly improve fibrosis in MASH patients in a Phase IIb study. The biotech crashed 53% in the aftermath of the readout.
June 27, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Innovent Announces Mazdutide, First Dual GCG/GLP-1 Receptor Agonist, Received Approval from China’s NMPA for Chronic Weight Management
June 27, 2025
·
13 min read
Press Releases
NUTEX HEALTH ANNOUNCES THAT IT HAS FILED A SUPPLEMENT TO ITS PROXY STATEMENT
June 27, 2025
·
3 min read
Press Releases
Course of Gubra A/S’ Extraordinary General Meeting Regarding Extraordinary Dividend
June 27, 2025
·
1 min read
Press Releases
Eton Pharmaceuticals Announces Addition to Russell 2000® and Russell 3000® Indexes
June 27, 2025
·
3 min read
Press Releases
Pharvaris Announces Clinical Trial Data Highlighting Deucrictibant for the Treatment of HAE to be Presented at the 2025 US HAEA National Summit
June 27, 2025
·
2 min read
Press Releases
HCW Biologics to Showcase Important Updates on IND-Enabling Studies and Preclinical Success of Its Novel Multi-Specific T-Cell Engagers Against Solid Tumors
June 27, 2025
·
6 min read
Press Releases
Turnstone Biologics Corp. Enters into Agreement to be Acquired by XOMA Royalty Corporation for $0.34 in Cash Per Share Plus a Contingent Value Right
June 27, 2025
·
8 min read
Press Releases
FOXO TECHNOLOGIES INC. DESIGNATES NEW SERIES OF PREFERRED STOCK TO BE USED FOR ACQUISITIONS
June 27, 2025
·
4 min read
Press Releases
BioCryst Announces Sale of European ORLADEYO® (berotralstat) Business to Neopharmed Gentili for up to $264 Million
June 27, 2025
·
8 min read
1 of 85,192
Next
